Privia Health Group, Inc.
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward do…
Medical - Healthcare Information Services
US, Arlington [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -1.45 | 722.07 | 732.72 | |
| Graham Fair Price | 3.59 | 1.66 | 1.60 | |
| PEG | 687.69 | 37.75 | -4.79 | |
| Price/Book | -19.38 | 3.91 | 4.84 | |
| Price/Cash Flow | 46.11 | -59.06 | 40.42 | |
| Prices/Earnings | -21.23 | 188.74 | 239.61 | |
| Price/Sales | -12.08 | 5.43 | 6.17 | |
| Price/FCF | 46.11 | -59.06 | 40.42 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 11.17 | 0.09 | 0.08 | |
| Operating Margin | -38.47 | < 0.005 | < 0.005 | |
| ROA | 1.91 | < 0.005 | < 0.005 | |
| ROE | < 0.005 | < 0.005 | 2.34 | |
| ROIC | < 0.005 | < 0.005 | -16.69 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | -0.09 | -0.08 | -19.74 | |
| Dividends QOQ | 0.00 | 0.00 | 0.00 | |
| EBIT QOQ | -0.74 | -0.42 | 43.45 | |
| EPS QOQ | -0.50 | 0.05 | -90.00 | |
| FCF QOQ | 2.00 | -1.57 | -21.59 | |
| Revenue QOQ | 0.06 | -0.06 | 2.86 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Balanced
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | < 0.005 | < 0.005 | 7.27 | |
| Days Sales Outstanding (DSO) | 59.36 | 75.01 | 26.36 | |
| Inventory Turnover | 403559000.00 | 376214000.00 | -6.78 | |
| Debt/Capitalization | 0.01 | 0.01 | -11.64 | |
| Quick Ratio | 1.76 | 1.73 | -1.78 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 4.75 | 4.87 | 2.39 | |
| Cash | 3.30 | 2.96 | -10.15 | |
| Capex | < 0.005 | -0.04 | -21592.55 | |
| Free Cash Flow | 0.57 | -0.32 | -43.51 | |
| Revenue | 3.73 | 3.50 | -6.12 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Bad
Fundamentals
Financial Health
06 - Financial Health ·
Weak